Filing metadata

Accession number
0001209191-21-020418
Form type
Form 4
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Mar 15, 2021
Reporting period
Mar 11, 2021
Description
Insider transaction

Explore SEC Filings Hub